Dr. Eure on clinical use and reimbursement of UroLift for BPH

“While there are other treatment options available for treating BPH, there remains a significant need for much less invasive treatment approaches that can preserve and protect the integrity of the urethra and other critical structures," says Ryan Rhodes.

The data were presented at the recent American Urological Association Annual Meeting.

A full market release of the HYDROS System is expected within the current quarter.

“Even though there [are] many therapies that one can do, it's not a sign of anything ominous for most men,” says Kevin T. McVary, MD, FACS.

The new Category I code will become effective on January 1, 2026.

"From a learning curve standpoint, there's not much to learn. It tends to be fairly quick in terms of your ability to do the procedure," says Matthew E. Sterling, MD.